Biomarkers in Parkinson's disease (recent update)

S Sharma, CS Moon, A Khogali, A Haidous… - Neurochemistry …, 2013 - Elsevier
Parkinson's disease (PD) is the second most common neurodegenerative disorder mostly
affecting the aging population over sixty. Cardinal symptoms including, tremors, muscle …

Proteostatic imbalance and protein spreading in amyotrophic lateral sclerosis

ME Cicardi, L Marrone, M Azzouz, D Trotti - The EMBO journal, 2021 - embopress.org
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder whose exact
causative mechanisms are still under intense investigation. Several lines of evidence …

Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer's disease

FH Duits, G Brinkmalm, CE Teunissen… - Alzheimer's research & …, 2018 - Springer
Background We investigated whether a panel of 12 potential novel biomarkers consisting of
proteins involved in synapse functioning and immunity would be able to distinguish patients …

Spatiotemporal proteomic profiling of Huntington's disease inclusions reveals widespread loss of protein function

F Hosp, S Gutiérrez-Ángel, MH Schaefer, J Cox… - Cell reports, 2017 - cell.com
Aggregation of polyglutamine-expanded huntingtin exon 1 (HttEx1) in Huntington's disease
(HD) proceeds from soluble oligomers to late-stage inclusions. The nature of the aggregates …

Fungal infection in patients with Alzheimer's disease

R Alonso, D Pisa, AI Marina, E Morato… - Journal of …, 2014 - content.iospress.com
Alzheimer's disease is a progressive neurodegenerative disorder that leads to dementia
mainly among the elderly. This disease is characterized by the presence in the brain of …

In-depth characterization of the cerebrospinal fluid (CSF) proteome displayed through the CSF proteome resource (CSF-PR)

A Guldbrandsen, H Vethe, Y Farag, E Oveland… - Molecular & cellular …, 2014 - ASBMB
In this study, the human cerebrospinal fluid (CSF) proteome was mapped using three
different strategies prior to Orbitrap LC-MS/MS analysis: SDS-PAGE and mixed mode …

Recent advances in quantitative neuroproteomics

GE Craft, A Chen, AC Nairn - Methods, 2013 - Elsevier
The field of proteomics is undergoing rapid development in a number of different areas
including improvements in mass spectrometric platforms, peptide identification algorithms …

Optical nanosensor for intracellular and intracranial detection of amyloid-beta

M Antman-Passig, E Wong, GR Frost, C Cupo, J Shah… - ACS …, 2022 - ACS Publications
Amyloid-beta (Aβ) deposition occurs in the early stages of Alzheimer's disease (AD), but the
early detection of Aβ is a persistent challenge. Herein, we engineered a near-infrared optical …

Identification of longitudinally dynamic biomarkers in Alzheimer's disease cerebrospinal fluid by targeted proteomics

KR Wildsmith, SP Schauer, AM Smith, D Arnott… - Molecular …, 2014 - Springer
Background Alzheimer's disease (AD) is the leading cause of dementia affecting greater
than 26 million people worldwide. Although cerebrospinal fluid (CSF) levels of Aβ 42, tau …

CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer's disease

J Remnestål, D Just, N Mitsios… - PROTEOMICS …, 2016 - Wiley Online Library
Purpose This study is part of a larger effort aiming to expand the knowledge of brain‐
enriched proteins in human cerebrospinal fluid (CSF) and to provide novel insight into the …